SANUWAVE Health, Inc.
Eden Prairie, MN · CIK 0001417663 · Medtech · Public
Acoustic pulse technology device for wound healing
sanuwave.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $81M
- 18 Form D · Jul 2024
- 27 months since last filing
- Contracts
- $117K
- 1 award · NASA
- #508 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $400,000 | |
| Private capital raised | Form D · SEC | $800,000 | |
| Private capital raised | Form D · SEC | $9,114,929 | |
| Private capital raised | Form D · SEC | $380,000 | |
| Private capital raised | Form D · SEC | $360,000 | |
| Private capital raised | Form D · SEC | $128,500 | |
| Private capital raised | Form D · SEC | $170,000 | |
| Private capital raised | Form D · SEC | $278,500 | |
| Private capital raised | Form D · SEC | $9,280,000 | |
| Private capital raised | Form D · SEC | $3,029,750 | |
| Private capital raised | Form D · SEC | $24,710,000 | |
| Federal contract | National Aeronautics and Space Administration · This Purchase Order Is For Acquiring Designs And A Demonstration Unit For Biofilm Mitigation Using Shock Wave Technology As Per Attached Quote 12192019 12/19/2019...DELIVERY Date: Receipt Of Award $72,593.17 12 Months Aro - $44,246.14 | $116,839 | |
| Private capital raised | Form D · SEC | $16,153,594 | |
| Private capital raised | Form D · SEC | $3,981,950 | |
| Private capital raised | Form D · SEC | $1,227,778 | |
| Private capital raised | Form D · SEC | $3,038,585 | |
| Private capital raised | Form D · SEC | $1,861,250 | |
| Private capital raised | Form D · SEC | $4,557,650 | |
| Private capital raised | Form D · SEC | $1,800,000 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 505 | AXCEND LLC | $123K | $7.2M |
| 506 | THE AIRD | $120K | — |
| 507 | SEATOX RESEARCH INC | $120K | — |
| 508 | SANUWAVE Health, Inc. | $117K | $81M |
| 509 | PURIGEN BIOSYSTEMS, INC. | $116K | $48M |
| 510 | Egg Medical, Inc. | $115K | $28M |
| 511 | CDI LABORATORIES, INC | $112K | $3.3M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jeff BlizardDirector
- Christopher CashmanDirector · Executive Officer
- Joseph ChiarelliDirector · Executive Officer
- Iulian CioantaExecutive Officer
- Morgan FrankDirector · Executive Officer
- Barry JenkinsExecutive Officer
- Maj-Britt KaltoftDirector
- Ian MillerDirector
- John NemelkaDirector
- Thomas PriceDirector
- Kevin RichardsonDirector · Executive Officer
- Kevin Richardson IIDirector · Executive Officer
- Kevin Richardson, IIExecutive Officer
- Toni RinowExecutive Officer
- Thomas RobinsonDirector
- Alan RubinoDirector
- John SchlechtwegExecutive Officer
- Peter SorensenExecutive Officer
- Peter StegagnoExecutive Officer
- Peter SteganoExecutive Officer
- A. StolarskiDirector
- A. Michael StolarskiDirector
- Anthony StolarskiDirector
- Michael StolarskiDirector
- Lisa SundstromExecutive Officer
- Lisa SundstrumExecutive Officer
- James TylerDirector
- Jim TylerDirector
- Andrew WalkoExecutive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.